3 Bay Area companies ramp up in quests for one-shot-and-done gene therapies By: San Francisco Business Times via Business Journals May 04, 2020 at 17:57 PM EDT Three separate milestones push toward gene therapy's big event — BioMarin's potential approval of a hemophilia A gene therapy. Read More >>